- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 10.71M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $112.91M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $105.41M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $7M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $6.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $26.68M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $24.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $97.98M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $97.04M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $285.09M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $267.57M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $148.84M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $144.77M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $396.57M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $385.2M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.52M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.06M |
| Capex | Q1 2025 · Mar 31, 2024 | $754K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.69M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $22.67M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.93M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.09M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $65.67M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $51.17M |
| Revenue | Q1 2025 · Mar 31, 2024 | $116.84M |